We further used immunohistochemistry to evaluate the expression of PGM5 protein in a wide spectrum of prostate tissues to determine its expression in situ, and evaluated the prognostic value of PGM5 in prostate cancer. This evidence concerns the gene PGM5 and prostate carcinoma.